z-logo
Premium
Comparison of the ORL1 receptor‐mediated inhibition of noradrenaline release in human and rat neocortical slices
Author(s) -
Rominger Axel,
Förster Stefan,
Zentner Josef,
Dooley David J,
McKnight Alexander T,
Feuerstein Thomas J,
Jackisch Rolf,
Vlaskovska Mila
Publication year - 2002
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0704523
Subject(s) - nociceptin receptor , idazoxan , desipramine , antagonist , chemistry , endocrinology , stimulation , tetrodotoxin , medicine , (+) naloxone , neocortex , receptor , prazosin , opioid peptide , biology , opioid , biochemistry , neuroscience , antidepressant , hippocampus
The effects of nociceptin/orphanin (N/OFQ) and the selective ORL1 antagonist J‐113397 (1‐[(3R,4R)‐1‐cyclo‐octylmethyl‐3‐hydroxymethyl‐4‐piperidyl]‐3‐ethyl‐1,3‐dihydro‐2H‐benzimidazol‐2‐one) were studied on electrically‐evoked release of [ 3 H]‐noradrenaline ([ 3 H]‐NA) from human and rat neocortical slices. Specimens of human tissue were obtained during neurosurgery. Slices were preincubated with 0.1 μ M [ 3 H]‐NA, superfused in the presence of desipramine, idazoxan, and naloxone (1 μ M each), and stimulated electrically up to three times under conditions (4 pulses, 100 Hz, 2 ms, 60 mA) that prevent inhibition of evoked [ 3 H]‐NA release by endogenous modulators accumulating during ongoing stimulation. N/OFQ decreased electrically‐evoked [ 3 H]‐NA release in both human and rat neocortical slices in a concentration‐dependent manner. The respective pEC 50 values were 7.74 [CI 95 : 7.47, 8.04] and 7.64 [CI 95 : 7.48, 7.77], and the maximal inhibitions were 36.9%[CI 95 : 32.4%, 41.8%] and 66.4%[CI 95 : 61.7%, 72.7%]. N/OFQ (1 μ M ) inhibited K + (15 m M )‐evoked [ 3 H]‐NA release from neocortical slices of both species by a similar magnitude, either in the presence or absence of tetrodotoxin. The nonpeptide ORL1 antagonist J‐113397 competitively attenuated, with similar potency, the inhibition of electrically‐evoked [ 3 H]‐NA release by N/OFQ in both species (pA 2 values: human, 8.16 [CI 95 : 7.64, 8.64]; rat, 8.47 [CI 95 : 8.27, 8.67]). J‐113397 (0.1 μ M ) by itself did not alter either the evoked or spontaneous [ 3 H]‐NA release, suggesting that presynaptic ORL1 receptors are not activated by endogenous N/OFQ under the stimulation conditions employed. This study provides the first evidence that N/OFQ modulates [ 3 H]‐NA release in human neocortex via specific ORL1 receptors most likely located on noradrenergic axon terminals.British Journal of Pharmacology (2002) 135 , 800–806; doi: 10.1038/sj.bjp.0704523

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom